Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07347106 · ClinicalTrials.gov registry record · NA
Miro3D Randomized Controlled Trial (RCT)
A NA study of Wound, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07347106 is a NA study of Wound that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 70 participants, below the 417-participant average among 8 other Wound trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07347106, a NA study of Wound, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the outcomes for patients managed with standard of care (SOC) wound treatments and those managed with standard of care treatment and tissue scaffolds, specifically Miro 3D. Tissue scaffolds like Miro 3D are 3-dimentional frameworks for collagen protein that provide structure and protection to help wounds heal.
Conditions Studied
Interventions
- OTHER Standard of Care Treatment or Standard of Care Treatment plus Miro3D Wound Matrix
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-01 |
| Est. Completion | 2028-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07347106
The ClinicalTrials.gov registry entry for NCT07347106 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 417-participant average among 8 other Wound trials with a reported enrollment target (83% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wound appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care Treatment or Standard of Care Treatment plus Miro3D Wound Matrix is the first listed.
NCT07347106 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT07347106 about?
NCT07347106 is a clinical study titled "Miro3D Randomized Controlled Trial (RCT)". The purpose of this research study is to evaluate the outcomes for patients managed with standard of care (SOC) wound treatments and those managed with standard of care treatment and tissue scaffolds, specifically Miro 3D. Tissue scaffolds like Miro 3D are 3-dimentional frameworks for collagen prote...
What is the current status of trial NCT07347106?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-01. Estimated completion is 2028-07.
What conditions does trial NCT07347106 study?
This clinical trial studies the following conditions: Wound.
What interventions are being tested in trial NCT07347106?
The interventions under investigation include: Standard of Care Treatment or Standard of Care Treatment plus Miro3D Wound Matrix (OTHER).
Who is sponsoring clinical trial NCT07347106?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07347106 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing
RECRUITING · NA
-
Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification
COMPLETED · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Novel Strategies for Reducing Burn Scar Itch
RECRUITING · Phase 3
-
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
RECRUITING · Phase 3
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.